CALADRIUS
Live / Registered — Registered (as of 24 Mar 2020)
What this means for you
Registered since 24 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86689885
- Registration number
- 6019100
- Mark type
- Stylized text
- Filed
- 10 Jul 2015
- Published for opposition
- 31 May 2016
- Registered
- 24 Mar 2020
- Attorney of record
- Charles T. J. Weigell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations in the fields of cardiology, vascular diseases, ischemic disorders
Owner
- Caladrius Biosciences, Inc., New York, NY, US
- Caladrius Biosciences, Inc., New York, NY, US
- Caladrius Biosciences, Inc., New York, NY, US
Prosecution history
- 24 Mar 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 21 Feb 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Feb 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Feb 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Feb 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Feb 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Aug 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Aug 2019 — NON-FINAL ACTION E-MAILED
- 19 Aug 2019 — SU - NON-FINAL ACTION - WRITTEN
- 29 Jul 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Jul 2019 — USE AMENDMENT FILED
- 26 Jul 2019 — TEAS STATEMENT OF USE RECEIVED